Filter
2290
Text search:
long
covid
Featured
Recommendations
284
New Publications
41
Language
Document type
Studies & Reports
936
Guidelines
539
Strategic & Response Plan
244
Manuals
204
Fact sheets
138
Situation Updates
66
Training Material
50
No document type
50
Resource Platforms
21
Brochures
17
Infographics
14
Videos
6
Online Courses
4
App
1
Countries / Regions
Global
257
Latin America and the Carribbean
78
Africa
68
Ukraine
55
India
49
West and Central Africa
48
East and Southern Africa
45
Kenya
43
Western and Central Europe
43
Syria
42
South Africa
37
Middle East and North Africa
37
Brazil
34
Russia
29
Congo, Democratic Republic of
28
Yemen
28
South–East Asia Region
28
Ethiopia
25
Germany
24
South Sudan
22
Nigeria
21
Burkina Faso
19
Eastern Europe and Central Asia
19
Haiti
18
Malawi
18
Mozambique
18
Senegal
17
Bangladesh
16
Niger
15
Namibia
15
Somalia
13
Western Pacific Region
13
Ghana
12
Afghanistan
12
Myanmar / Burma
12
Mali
11
Uganda
11
Colombia
11
Pakistan
10
Central African Republic
10
Philippines
9
Lebanon
9
Chad
9
Sudan
9
Venezuela
9
Vietnam
9
Côte d’Ivoire / Ivory Coast
8
Cameroon
8
Zambia
8
Indonesia
8
Argentina
8
Chile
8
France
8
Liberia
7
Tanzania
7
Cambodia
7
China
7
Rwanda
7
Peru
7
Burundi
7
Madagascar
7
Eastern Europe
7
Palestine
7
Jordan
6
Thailand
6
Angola
6
Asia
6
Moldova
6
North America
6
Sierra Leone
5
Zimbabwe
5
Nepal
5
Iraq
5
Benin
5
Mexico
5
Laos
5
Congo-Brazzaville
5
Jamaica
5
United Kingdom
5
Spain
5
Guinea
4
Guinea-Bissau
4
Togo
4
Hungary
4
Ecuador
4
Lesotho
4
Papua New Guinea
3
Eswatini/ Swaziland
3
Bolivia
3
Libya
3
Djibouti
3
Iran
3
Portugal
3
USA
2
Turkey
2
Egypt
2
Malaysia
2
Mauritania
2
Ireland
2
Greece
2
Sri Lanka
2
Paraguay
2
Luxembourg
2
Poland
2
Italy
2
Canada
2
Bulgaria
2
Romania
2
Belgium
2
Mauritius
2
Tunisia
2
Morocco
1
Saudi Arabia
1
Gambia
1
Vanuatu
1
North Macedonia
1
Switzerland
1
Botswana
1
El Salvador
1
Nicaragua
1
Fiji
1
Solomon Islands
1
North Korea
1
Armenia
1
Mongolia
1
Timor Leste/ East Timor
1
Slovakia
1
Uzbekistan
1
Kyrgyzstan
1
Kazakhstan
1
Georgia
1
Gabon
1
Turkmenistan
1
Japan
1
Norway
1
South Korea
1
Algeria
1
Belarus
1
French Guyana
1
Israel
1
Guyana
1
Authors & Publishers
Publication Years
Category
Countries
800
Public Health
135
Key Resources
135
Women & Child Health
91
Clinical Guidelines
79
Capacity Building
33
Pharmacy & Technologies
21
Annual Report MEDBOX
2
Toolboxes
COVID-19
1027
Planetary Health
179
Conflict
110
Health Financing Toolbox
87
Mental Health
82
Caregiver
75
HIV
74
Refugee
69
NCDs
61
Malaria
48
Global Health Education
47
NTDs
42
TB
38
AMR
34
Rapid Response
32
2.0 Rapid Response
32
Natural Hazards
24
Disability
17
Pharmacy
17
Cholera
7
Ebola & Marburg
6
Polio
6
Zika
4
Social Ethics
4
Specific Hazards
1
Настоящее руководство «Клиническое ведение случаев COVID-19» базируется на
вышеуказанных стратегических приоритетах и адресовано клини
...
n light of the potential risk posed by SARS-CoV-2 variants, in January 2021 WHO organized an ad hoc consultation to discuss the development of an R&D agenda in response to existing and emerging SARS-CoV-2 variants.
The key objectives were to identify the critical research questions related to var
...
COVID Reference 2021.6 EN
recommended
6th edition 13 January 2021 CR 2021.6.10, uploaded on 27 May 2021
Find eight editions: Deutsch | English | Español | Français | Italiano | Português | Tiếng Việt | Türkçe
https://covidreference.com/download
Les infections au SRAS-CoV-2 chez les enfants et les adolescents provoquent une maladie moins grave et moins de décès que chez les adultes. Bien qu'une évolution moins grave de l'infection soit un résultat positif, on s'inquiète du fait que des symptômes légers aient pu conduire à moins de t
...
The Lancet Published Online
October 8, 2021 https://doi.org/10.1016/ S0140-6736(21)02143-7
La dosis de refuerzo está indicada una vez transcurridos los 4 meses (120 días) de la última dosis del esquema inicial y será con vacuna de plataforma ARNm: Pfizer-BioNTech pediátrica a partir de los 5 años o Moderna para uso pediátrico a partir de los 6 años.
This report’s central premise is that diagnostics and therapeutics, and associated test to treat strategies, are fundamental components of the pandemic response, both for COVID-19 and for future health threats. Two years into the
...
The COVID-19 pandemic is having far reaching impacts, well beyond the health crisis and needs, with the most severe impacts experienced in the poorest countries and those most vulnerable to humanitarian crises including natural disasters, such as Ne
...
As information about COVID-19 is rapidly evolving, it can be challenging to navigate and synthesize all of the information. The purpose of this document is to provide a synthesized, indexed reference of accurate, standardized
...
Les notes d’orientation décrivent les mesures essentielles que les décideurs nationaux et infranationaux peuvent mettre en place concernant les aspects suivants de la lutte contre la COVID-19 : les tests de diagnostic, la prise en charge cliniqu
...
In 2020, the COVID-19 pandemic impacted the world beyond imagination. To date, it has infected more than 135 million people, killed over 2.9 million people, and is projected to plunge up to 115 million people into extreme poverty.1 As countries have
...
This document aims to encourage countries to develop and implement policies to maintain and strengthen IPC programmes and measures in health care facilities in the context of the current ongoing transmission of the SARS-CoV-2, with recognition that epidemiological trends may vary and the risk of tra
...
Rethinking Health with Covid-19 Lessons and Challenges
Este e-book que integra estratégias de três Projetos PROADISUS (Lean nas Emergências, Reab pós-COVID-19 e Cuidados Paliativos) e expõe te
...
Временные рекомендации27 мая 2021 г.
Impact of non-pharmaceutical interventions (NPIs) to reduce COVID-19 mortality and healthcare demand
recommended
The global impact of COVID-19 has been profound, and the public health threat it represents is the most serious seen in a respiratory virus since the 1918 H1N1 influenza pandemic. Here we present the results of epidemiological modelling which has in
...
Laboratory biosafety guidance related to coronavirus disease (COVID-19): Interim guidance, 28 January 2021
recommended
The latest update (28 January 2021) includes the following addition and revision:
biosafety aspects for working with antigen-detecting rapid diagnostic test;
handling new variants of SARS-CoV-2 in the laboratory;
updated assay decontamination before disposal;
personal protectiv
...
The COVID-19 HEalth caRe wOrkErs Study (HEROES): Regional Report from the Americas is a multicenter prospective cohort study to assess the impact of the COVID-19 pandemic on the mental health of hea
...